Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum

NCT: NCT06453850 · COMPLETED

NCT IDNCT06453850
StatusCOMPLETED
Start Date2025-02-14
Completion2026-04-30
SponsorMicroPort CRM (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the clinical investigation is to evaluate the safety of the FLEXIGO delivery catheter for transvenous pacing lead implantation.

Frequently Asked Questions

What is Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum?

Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum is a clinical trial registered under NCT06453850. Current status: COMPLETED.

What is the status of NCT06453850?

The current status of NCT06453850 (Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum) is: COMPLETED.

When did Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum start?

Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum started on 2025-02-14.

Related Devices

K250492FlexiGo 3D Delivery CatheterCenterPoint Systems, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑